WASHINGTON, Aug. 25, 2016 /PRNewswire/ -- In December 2015, the FDA issued a proposed orderto down-classify the device used to deliver electroshock therapy. Today, Attorney Jonathan Emord filed a Citizens Petition with the FDA on behalf of 5 individuals who were damaged by electroshock.
"I hope this
Most people surveyed thought electroshock therapy, also called electroconvulsive therapy or ECT, did go the way of lobotomies. In fact, a conservative estimate is that over 100,000 individuals receive electroshock therapy each year in the U.S. Actual numbers are not available because there is no tracking of this.
The ECT procedure involves shooting up to 450 volts of electricity through the brain, intentionally causing a massive seizure. According to the FDA, electroshock therapy can cause cognitive impairment, memory impairment, prolonged seizures, dental trauma, manic symptoms, pulmonary complications, worsening of psychiatric symptoms, and death.
The ECT devices have never gone through standard clinical trials to establish safety and efficacy. The FDA has requested studies a number of times and the manufacturers have ignored them an equal number of times. The FDA has neglected to follow through, failing to take action to protect the public. Instead, the FDA issued the proposed order to reclassify the ECT device to a safer category, in the absence of clinical trial data establishing safety.
According to Emord, the FDA has gone against its own precedents and policies in its handling of the ECT device.
The FDA has reasons to be concerned:
"People talk about the memory loss, but what's worse is shock [ECT] destroys your ability to form relationships. You can't trust anybody because you've been betrayed so bad." ECT survivor
Emord's petition exposes step-by-step how the FDA failed to protect patients in its proposed rule.
The FDA admits ECT can cause death, cardiovascular complications, memory loss, and cognitive impairment. The manufacturers admit in written submissions to the FDA that ECT does not provide benefits after the treatment stops. The petition confronts the FDA with these facts and their conclusion that the benefits outweigh the risks. Emord points out the FDA provides no explanation for why a device that can cause death and brain damage has not been required and is not now being required to submit standard clinical trial data to prove safety and efficacy.
For more information contact Dr. Linda Lagemann, who represents the damaged persons.
A copy of the Petition is available here, along with supporting Exhibits (Part 1, Part 2, and Part 3).
Contact: Dr. Linda Lagemann 415-640-7343Email: 2DrLagemann@gmail.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/attorney-jonathan-emord-takes-on-the-fda-over-electroshock-ect-device-300318482.html
SOURCE Emord & Associates, P.C.
Subscribe to our Free Newsletters!
Cachexia refers to severe muscle and fat loss, anorexia and marked weight loss due to an underlying ...
Exotropia or outward eye deviation is a form of squint. Proper evaluation and timely intervention ...
Glaucoma is a group of disorders involving the optic nerve, often associated with a rise in ...View All